EMERYVILLE, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Bionovo, Inc. , a leader in the discovery and development of safe and effective drugs in the areas of women's health and cancer, today announced that Tom Chesterman, SVP and CFO of Bionovo, Inc., will present at the 4th Annual BIO Investor Forum.
The presentation will take place on October 11, 2007 at 12:30 p.m. PDT at the Palace Hotel in San Francisco, CA.
A live audio web cast and slide presentation of the event will be available via a link at: http://www.bionovo.com.
Bionovo, Inc.
Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the Nasdaq Capital Market under the symbol BNVI. For more information about Bionovo and its programs, visit http://www.bionovo.com.
CONTACT: Tom Chesterman, SVP & CFO, +1-510-420-4189,
tchesterman@bionovo.com, or Media, Katherina Audley, +1-415-847-7295,
katherina.audley@bionovo.com, both of Bionovo, Inc.
Web site: http://www.bionovo.com/
